Beat Childhood Cancer Foundation Inc is located in Braintree, MA. The organization was established in 2010. According to its NTEE Classification (H19) the organization is classified as: Support N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2021, Beat Childhood Cancer Foundation Inc employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Beat Childhood Cancer Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Beat Childhood Cancer Foundation Inc generated $1.6m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 21.3% each year . All expenses for the organization totaled $1.9m during the year ending 12/2021. While expenses have increased by 10.9% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. OUR VISION IS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING VIABLE TREATMENTS AND ULTIMATELY, CURES FOR CHILDHOOD CANCERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
BEAT CHILDHOOD CANCER DRIVES CHILDHOOD CANCER RESEARCH AND RAISES AWARENESS, MAKING A DIFFERENCE IN KIDS' SURVIVAL TODAY. THE ORGANIZATION AIMS TO CHANGE THE STORY FOR THE NEXT FAMILY BY FINDING VIABLE TREATMENTS AND ULTIMATELY, CURES FOR CHILDHOOD CANCERS. THE PRIMARY PURPOSE AND ACTIVITY OF BEAT CHILDHOOD CANCER IS TO RAISE FUNDS TO FACILITATE RESEARCH GRANTS TO BEAT CHILDHOOD CANCER RESEARCH CONSORTIUM.BEAT CHILDHOOD CANCER DRIVES PATIENT-AFFECTING CHILDHOOD CANCER CLINICAL TRIALS, EXPANDING HOW RESEARCH IS DONE. PRECISION MEDICINE IS THE FUTURE OF CANCER TREATMENT. WE ARE HELPING KIDS NOW WITH TARGETED THERAPIES AND ORAL DRUGS WITH LOW SIDE EFFECTS AIMED AT PREVENTING OR TREATING RELAPSE WITHOUT PUNITIVE, LONG-TERM SIDE EFFECTS. OUR COMMUNITY OF CLINICIANS, SCIENTISTS, PARENTS, AND SUPPORTERS HAS BUILT AN INTERNATIONAL INFRASTRUCTURE AND TEAM OF RESEARCH AND CLINICAL COLLABORATORS TO ENSURE KIDS HAVE ACCESS TO THESE THERAPIES.SINCE 2010, OUR GROUP HAS OPENED NINETEEN CLINICAL TRIALS, DIRECTLY AFFECTING MORE THAN 1,000 KIDS. WHERE THE TRADITIONAL CLINICAL TRIAL MODEL OFTEN TAKES SEVERAL YEARS TO START ENROLLING PATIENTS, THE BEAT CHILDHOOD CANCER RESEARCH CONSORTIUM USUALLY ENROLLS CHILDREN ON CLINICAL TRIALS WITHIN ONE YEAR. OUR PATIENT-CENTERED FOCUS IS NOT BASED ON A SINGLE DOCTOR, HOSPITAL, OR DRUG. IT IS ABOUT HELPING EVERY CHILD, EVERYWHERE SURVIVE AND THRIVE FOLLOWING A CHILDHOOD CANCER DIAGNOSIS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Kyle Matthews Executive Director/clerk | OfficerTrustee | 40 | $110,000 |
Patrick Lacey President | OfficerTrustee | 20 | $0 |
Eric Caisse Treasurer | OfficerTrustee | 5 | $0 |
Brian Shactman Director | Trustee | 5 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $531,420 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $1,210,497 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,741,917 |
Total Program Service Revenue | $0 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | -$113,581 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,628,336 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,450,000 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $110,000 |
Compensation of current officers, directors, key employees. | $33,000 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $61,561 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $14,245 |
Payroll taxes | $13,102 |
Fees for services: Management | $0 |
Fees for services: Legal | $2,890 |
Fees for services: Accounting | $12,378 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $64,000 |
Advertising and promotion | $15,702 |
Office expenses | $52,960 |
Information technology | $1,427 |
Royalties | $0 |
Occupancy | $0 |
Travel | $21,058 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $1,900 |
Insurance | $3,854 |
All other expenses | $0 |
Total functional expenses | $1,909,225 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,878,368 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $65,000 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $6,650 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $1,950,018 |
Accounts payable and accrued expenses | $13,487 |
Grants payable | $1,350,000 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $1,363,487 |
Net assets without donor restrictions | $378,039 |
Net assets with donor restrictions | $208,492 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $1,950,018 |
Over the last fiscal year, we have identified 1 grants that Beat Childhood Cancer Foundation Inc has recieved totaling $25,000.
Awarding Organization | Amount |
---|---|
Mighty Millie Foundation Inc Marietta, GA PURPOSE: PEDIATRIC CANCER RESEARCH GRANT | $25,000 |
Organization Name | Assets | Revenue |
---|---|---|
South Shore Health Express Inc South Weymouth, MA | $32,089,469 | $12,224,356 |
Beat Childhood Cancer Foundation Inc Braintree, MA | $1,950,018 | $1,628,336 |
Galien Foundation Inc New York, NY | $3,140,847 | $2,038,143 |
Full Steam Forward Inc Boston, MA | $199,302 | $229,396 |
Zebrafish Disease Models Society Clifton Park, NY | $286,470 | $0 |
International Thymic Malignancy Interest Group Sleepy Hollow, NY | $146,340 | $0 |
Alexanders Angels Inc Jericho, NY | $33,601 | $0 |
Ponde Family Foundation Milton, MA | $7,771 | $0 |
Med Man Simulations Inc Chestnut Hill, MA | $84,214 | $0 |
Puzzle Solvers Cortland, NY | $23,736 | $0 |
N Y Academy Of Medicine Ttee 124538 New York, NY | $158,350 | $3,224 |
Wong & Sun Family Foundation Old Westbury, NY | $15,802 | $0 |